227322-00-1

Basic information

• Product Name: 2-Cyclopropyl-N-methoxy-N-methyl-acetamide
• Synonyms: 2-Cyclopropyl-N-methoxy-N-methyl-acetamide
• CAS NO: 227322-00-1
• Molecular Formula: C₇H₁₃NO₂
• Molecular Weight: 143.18362
• Mol File: 227322-00-1.mol
• Article Data: 19

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-Cyclopropyl-N-methoxy-N-methyl-acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Cyclopropyl-N-methoxy-N-methyl-acetamide(227322-00-1)
• EPA Substance Registry System: 2-Cyclopropyl-N-methoxy-N-methyl-acetamide(227322-00-1)

Safety Data

• Hazardous Substances Data: 227322-00-1(Hazardous Substances Data)

Upstream product

• 6542-60-5 2-cyclopropylacetonitrile 
• 5239-82-7 cyclopropylacetic acid 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 
• 1117-97-1 N,0-dimethylhydroxylamine 
• 530-62-1 1,1'-carbonyldiimidazole 

Downstream Products

• 1352754-36-9 3-[(S)-1-(4-bromo-phenyl)-ethyl]-6-cyclopropylmethyl-6-(2-methyl-allyl)-[1,3]oxazinan-2-one 
• 1352754-34-7 4-[(S)-1-(4-bromo-phenyl)-ethylamino]-1-cyclopropyl-butan-2-one 
• 1352754-35-8 1-[(S)-1-(4-bromo-phenyl)-ethylamino]-3-cyclopropylmethyl-5-methyl-hex-5-en-3-ol 
• 1352754-37-0 3-[(S)-1-(4-bromo-phenyl)-ethyl]-6-cyclopropylmethyl-6-(2-methyl-oxiranylmethyl)-[1,3]oxazinan-2-one 
• 1352754-39-2 3-[(S)-1-(4-bromo-phenyl)-ethyl]-(S)-6-cyclopropylmethyl-6-(2-hydroxy-2-methyl-propyl)-[1,3]oxazinan-2-one 
• 1352754-38-1 (S)-6-cyclopropylmethyl-6-(2-hydroxy-2-methyl-propyl)-3-{(S)-1-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-ethyl}-[1,3]oxazinan-2-one 
• 1352753-96-8 1-[5-(4-{(S)-1-[(S)-6-cyclopropylmethyl-6-(2-hydroxy-2-methyl-propyl)-2-oxo-[1,3]oxazinan-3-yl]-ethyl}-phenyl)-pyridin-2-yl]-cyclopropanecarboxylic acid amide 
• 1452490-55-9 tert-butyl((2-fluorobenzyl)oxy)dimethylsilane 
• 658076-48-3 1-bromo-3-cyclopropylpropan-2-one 

Relevant articles and documents

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis using such modulators and pharmaceutical compositions, and processes for making such modulators.

FERROPORTIN INHIBITORS AND METHODS OF USE

The subject matter described herein is directed to Ferroportin inhibitor compounds of Formula I and pharmaceutical salts thereof, methods of preparing the compounds, pharmaceutical compositions comprising the compounds and methods of administering the compounds for prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, particularly iron overload states, such as thalassemia, sickle cell disease and hemochromatosis.

4-(2,4-BIS(2-HYDROXYPHENYL)-1H-IMIDAZOL-1-YL)BENZOIC ACID DERIVATIVES AS NOVEL IRON CHELATORS

The invention relates to novel compounds of the general formula (I) pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for the use as iron chelators, more particularly for the use in the prophylaxis and/or treatm